Literature DB >> 12420367

Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?

Alan M Jacobson1, Jacqueline A Samson, Katie Weinger, Christopher M Ryan.   

Abstract

In summary, our review of the literature suggests that diabetes, especially type 1 diabetes, may place patients at risk for a depressive disorder through a biological mechanism linking the metabolic changes of diabetes to changes in brain structure and function. Further studies are warranted examining these relationships in order to better understand the impact of diabetes on brain functioning and structure as well as one potential manifestation of such changes--affective disorder. Moreover, such studies could play a useful role in better understanding mechanisms that commonly underlie the development of depression in individuals without diabetes but with other medical problems or conditions.

Entities:  

Mesh:

Year:  2002        PMID: 12420367     DOI: 10.1016/s0074-7742(02)51013-8

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  14 in total

Review 1.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

2.  Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

Authors:  Sukhdev Singh Kamboj; Kanwaljit Chopra; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2008-09-19       Impact factor: 3.584

3.  Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats.

Authors:  Marzia Pesaresi; Silvia Giatti; Donato Calabrese; Omar Maschi; Donatella Caruso; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2010-03-27       Impact factor: 3.444

4.  Insulin Signaling Deficiency Produces Immobility in Caenorhabditis elegans That Models Diminished Motivation States in Man and Responds to Antidepressants.

Authors:  Julie Dagenhardt; Angeline Trinh; Halen Sumner; Jeffrey Scott; Eric Aamodt; Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2017-09-21

5.  Prefronto-temporal white matter microstructural alterations 20 years after the diagnosis of type 1 diabetes mellitus.

Authors:  Sujung Yoon; Jungyoon Kim; Gail Musen; Perry F Renshaw; Jaeuk Hwang; Nicolas R Bolo; Jieun E Kim; Donald C Simonson; Katie Weinger; Christopher M Ryan; In Kyoon Lyoo; Alan M Jacobson
Journal:  Pediatr Diabetes       Date:  2017-09-20       Impact factor: 4.866

Review 6.  Anxiety and depression in children and adolescents with sickle cell disease.

Authors:  Tami D Benton; Judith A Ifeagwu; Kim Smith-Whitley
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

7.  Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Authors:  In Kyoon Lyoo; Sujung Yoon; Alan M Jacobson; Jaeuk Hwang; Gail Musen; Jieun E Kim; Donald C Simonson; Sujin Bae; Nicolas Bolo; Dajung J Kim; Katie Weinger; Junghyun H Lee; Christopher M Ryan; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2012-12

Review 8.  Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation.

Authors:  Jerusha B Detweiler-Bedell; Michael A Friedman; Howard Leventhal; Ivan W Miller; Elaine A Leventhal
Journal:  Clin Psychol Rev       Date:  2008-09-09

Review 9.  Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.

Authors:  Silvia Giatti; Silvia Diviccaro; Roberto Cosimo Melcangi
Journal:  Cell Mol Neurobiol       Date:  2018-08-14       Impact factor: 5.046

10.  A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder.

Authors:  Anusha Baskaran; Roumen Milev; Roger S McIntyre
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-17       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.